IDH3G Antibody - Cat. #: CSB-PA952993

SKU: CSB-PA952993

Size :50ul

Clone Number:

Aliases:H IDHG antibody; IDH gamma antibody; IDH3G antibody; IDH3G_HUMAN antibody; Isocitrate dehydrogenase [NAD] subunit gamma antibody; Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial antibody; Isocitrate dehydrogenase 3 (NAD+) gamma antibody; Isocitric dehydrogenase antibody; Isocitric dehydrogenase subunit gamma antibody; mitochondrial antibody; NAD (H) specific isocitrate dehydrogenase gamma subunit antibody; NAD(+) specific ICDH antibody; NAD(+)-specific ICDH subunit gamma antibody; NAD+ specific ICDH antibody; OTTHUMP00000025984 antibody; OTTHUMP00000025985 antibody; OTTHUMP00000025987 antibody; OTTHUMP00000025988 antibody; OTTHUMP00000214764 antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:P51553

Immunogen:Fusion protein of Human IDH3G

Raised in:Rabbit

Species Reactivity:Human, Mouse, Rat

Tested Applications:ELISA, WB, IHC; ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

Background:Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit.

Clonality:Polyclonal

Isotype:IgG

Purification Method:Antigen affinity purification

Conjugate:Non-conjugated

Buffer:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:IDH3G

Research Areas:Cancer;Metabolism;Signal transduction